"Switching to an oral product will be safer than using an inhalable product of any type,"
These small, tobacco-free pouches are gaining popularity, particularly among young adults in the U.S. and beyond.
Used without combustion, Oral Nicotine Pouches (ONPs) deliver relatively pure nicotine with far fewer harmful substances than smoked or vaped products.
Their toxicant levels are close to those found in traditional nicotine replacement therapies (NRTs), reinforcing their potential as a harm reduction tool.
Professor Benowitz stressed that encouraging smokers to switch to ONPs could have major public health benefits.
Clinical trials are currently underway to assess their effectiveness in helping people quit smoking, and early evidence is promising.
He also said that beyond cessation, many users report additional benefits.
ONPs (which contain nicotine) are said to improve mood, enhance concentration during study or work, and aid focus in sports such as golf and baseball.
They’re also used socially, especially in settings where smoking isn’t permitted.
Benowitz acknowledged that while nicotine use is likely to continue, providing safer alternatives like ONPs is key.
He noted strong evidence that nicotine can support cognitive function, and some anecdotal reports suggest performance benefits in sports.
Although more research is needed, early findings and real-world usage suggest ONPs could play a crucial role in reducing tobacco-related harm.
With increased awareness and thoughtful regulation, they may soon be recognised as a valuable aid for smokers looking to quit.
"It’s encouraging to see innovation that supports harm reduction. ONPs could become a real game-changer for those wanting a safer alternative,"